Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

106 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Completed

Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer

NCT00371553

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada
  • Cancer Care Manitoba Winnipeg, Manitoba, Canada
  • QEII Health Science Center Halifax, Nova Scotia, Canada
View Trial Details
Active, Not Recruiting

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

NCT01873326

Conditions
Germ Cell Tumors, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

NCT02375204

Conditions
Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 125 locations
View Trial Details
Active, Not Recruiting

A Study of miRNA 371 in Patients With Germ Cell Tumors

NCT04435756

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +20 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 424 locations
View Trial Details
Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

NCT03158064

Conditions
Dysgerminoma, Germ Cell Tumor, Germinoma, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details

Related conditions